1. Lasagna L. Clinical pharmacology: present status and future development. Science. 1966; 152:388–391.
Article
2. Spechtmeyer H. Klinische Pharmakologie in den USA. I. Entwicklung der klinischen Pharmakologie. [Clinical pharmacology in the USA. I. Development of clinical pharmacology.] Med Welt. 1968; 35:1833–1837.
3. Uvnäs B. Klinisk farmakologi (6): utvecklingen i Sverige. [Clinical pharmacology (6): development in Sweden.]. Lakartidningen. 1970; 67:1918–1922.
4. Kampffmeyer H. Impact of the West German drug law upon development of clinical pharmacology. Clin Pharmacol Ther. 1974; 16:616–619.
5. Dollery CT. Report on the development of clinical pharmacology. N Z Med J. 1974; 80:222–223.
6. Morgan JP. Academic clinical pharmacology: development, current and future status. J Clin Pharmacol. 1975; 15:725–730.
Article
7. Naranjo CA. Farmacologia clinica en Chile: estado actual y desarrollo futuro. [Clinical pharmacology in Chile: current state and future development.]. Rev Med Chil. 1978; 106:165–169.
8. Miller RR. History of clinical pharmacy and clinical pharmacology. J Clin Pharmacol. 1981; 21:195–197.
Article
9. Aagaard GN (editor). Ninety years of therapeutics: a history of the American Society for Clinical Pharmacology and Therapeutics. Clin Pharmacol Ther. 1990; 47:247–304.
10. Reidenberg MM. The history of Clinical Pharmacology & Therapeutics. Clin Pharmacol Ther. 1990; 47:277–9.
11. Jané F. Professional prospects in clinical pharmacology. History and present situation in Spain. Methods Find Exp Clin Pharmacol. 1996; 18(Suppl C)::5–7.
12. Heath G, Colburn WA. An evolution of drug development and clinical pharmacology during the 20th century. J Clin Pharmacol. 2000; 40:918–929.
Article
13. Igić R. [Contribution to the history of clinical pharmacology in former Yugoslavia.] Vojnosanit Pregl. 2007; 64:573–574.
14. Kshirsagar N, Kumar V. Clinical pharmacology: prospects and development in India. Indian J Pharmacol. 2011; 43:489–91.
Article
15. Sjöqvist F. Development of clinical pharmacology as a medical speciality in Europe–the roles of WHO, IUPHAR and EACPT. Basic Clin Pharmacol Toxicol. 2014; 115:172–178.
16. Shin S-G. History of clinical pharmacology in Korea. Transl Clin Pharmacol. 2014; 22:43–51. http://dx.doi.org/10.12793/tcp.2014.22.2.43.
Article
17. Montastruc P. Histoire de la pharmacologie clinique en France: dans une scintillante introspective, l'adaptation, l'évaluation, la défense et l'illustration du médicament en France 1978–1981. [History of clinical pharmacology in France: adaptation, evaluation, defense and illustration of drug in France 1978–1981.] Thérapie. 2014; 69:481–482.
18. Zagorodnikova Goryachkina K, Burbello A, Sychev D, Frolov M, Kukes V, Petrov V. Clinical pharmacology in Russia–historical development and current state. Eur J Clin Pharmacol. 2015; 71:159–163.
Article
19. Gaw A. "The principles of a future pharmacology": Johann Christian Reil (1759–1813) and his role in the development of clinical pharmacology. Eur J Clin Pharmacol. 2016; 72:13–17.
Article
20. Laurence D. What is pharmacology? A discussion. Trends Pharmacol Sci. 1997; 18:153–155.
Article
21. Aronson JK. Medication errors: definitions and classification. Br J Clin Pharmacol. 2009; 67:599–604.
Article
22. Black JW. TiPS on identity. Trends Pharmacol Sci. 1996; 17:121.
Article
23. Aronson JK. A manifesto for clinical pharmacology from principles to practice. Br J Clin Pharmacol. 2010; 70:3–13.
Article
24. Aronson JK. Integrating pharmacology and clinical pharmacology. Br J Clin Pharmacol. 2011; 71:787–790.
Article
25. Martin JH, Henry D, Gray J, Day R, Bochner F, Ferro A, et al. Achieving the World Health Organization's vision for clinical pharmacology. Br J Clin Pharmacol. 2016; 81:223–227.
Article
26. Birkett D, Br⊘sen K, Cascorbi I, Gustafsson LL, Maxwell S, Rago L, et al. Clinical pharmacology in research, teaching and health care. Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology. Basic Clin Pharmacol Toxicol. 2010; 107:531–559.
27. Aronson J. When I use a word… Materia medica, clinical pharmacology, and therapeutics. QJM. 2010; 103:361–363.
28. Oxford English Dictionary. http://ezproxy-prd.bodleian.ox.ac.uk. 2355/view/Entry/114933?redirectedFrom=materia+medica#eid.
29. Martini P. Methodenlehre der Therapeutischen Untersuchung. Berlin: Springer Verlag;1932.
30. Shelley JH, Baur MP. Paul Martini: the first clinical pharmacologist? Lancet. 1999; 353:1870–1873.
Article
31. Gaddum JH. Clinical pharmacology. Proc R Soc Med. 1954; 47:195–204.
Article
32. Brainerd HD, Bruyn HB, Meiklejohn G, O'Gara L. Estudios sobre la farma-cología clínica de Aureomicina. [Studies on the clinical pharmacology of aureomycin.] Pan Am Med Woman's J. 1952; 59:14–20.
33. Laurence DR. Quantitative Methods in Human Pharmacology and Therapeutics. London: Pergamon Press;1959.
34. Reynolds LA, Tansey EM. Clinical Pharmacology in the UK, c. 1950–2000: Influences and Institutions. Wellcome Witnesses to Twentieth Century Medicine. Volume 33:2008. London: The Wellcome Trust Centre for the History of Medicine at UCL;http://www.histmodbiomed.org/witsem/vol33.
35. Anonymous. The image of clinical pharmacology. Lancet. 1970; 295:129.
36. Williams G. Misleading, unscientific, and unjust: the United Kingdom's research assessment exercise. BMJ. 1998; 316:1079–1082.
Article
37. Tomlinson S. The research assessment exercise and medical research. BMJ. 2000; 320:636–639.
Article
38. Banatvala J, Bell P, Symonds M. The Research Assessment Exercise is bad for UK medicine. Lancet. 2005; 365:458–460.
Article
39. Mroz A. First, let's find out if it will fly. Times Higher Educ. 2009 December 17. http://www.timeshighereducation.co.uk/story.asp?sectioncode=26&st. orycode=409630.
40. Collini S. Impact on humanities. Times Lit Suppl. 2009 November; 13:18–19.
41. Maxwell SR, Webb DJ. Clinical pharmacology–too young to die? Lancet. 2006; 367:799–800.
Article
42. Pirmohamed M, Webb D, Rang H. A prescription for the NHS. Recognising the value of clinical pharmacology and therapeutics.https://www.bps.ac.uk/BPSMemberPortal/media/BPSWebsite/BPS_A_prescription_for_the_NHS_FINAL_SP. (1).pdf.
43. Aronson JK. Clinical pharmacology and therapeutics in the UK–a great instauration. Br J Clin Pharmacol. 2010; 69:111–117.
44. Aronson JK. Finding a VOICE for UK clinical pharmacology. Br J Clin Pharmacol. 2012; 73:843–845.
Article
45. Aronson JK, Velo G. Towards a single VOICE for European clinical pharmacology: proposals for future developments. Eur J Clin Pharmacol. 2013; 69:1981–1984.
Article
47. British Pharmacological Society. The Society publishes "Clinical Pharmacology: A dynamic medical speciality essential for UK Healthcare". https://www.bps.ac.uk/news-events/news/society-news/articles/the-society-publishes-clinical-pharmacology-a-dy.
48. British Pharmacological Society. Clinical Pharmacology: a Dynamic Medical Speciality Essential for UK Healthcare". https://www.bps.ac.uk/BPS-MemberPortal/media/BPSWebsite/Clinical-Pharmacology-A-dynamic-medical-speciality-essential-for-UK-Healthcare.pdf.
49. Welsh Government. Investing to save 3: Short-term investment for longterm benefit. 2012. http://gov.wales/docs/dpsp/publications/valuewales/12. 1107i2s3final.pdf.
50. British Pharmacological Society. British Pharmacological Society Ambassadors. https://www.bps.ac.uk/my-society/get-involved/british-pharmacological-society-ambassadors.